Ayvakit 200 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LX7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,345
Award facts
- Contract value 100% obligated
- $26,345.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26.3K to AmerisourceBergen Drug Corp for 30 tablets of AYVAKIT 200 mg, a pharmaceutical product for oncology treatment. The contract, issued on January 20, 2026, with completion targeted for February 10, 2026, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed as a child contract under AmerisourceBergen's parent company, Cencora, Inc., which operates under the Amerisourcebergen trade name.
This award derives from Cencora, Inc.'s significant Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999.9M through December 31, 2031. This primary vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. AmerisourceBergen's substantial presence in federal pharmaceutical procurement reflects its critical role in supplying essential medications to the Defense Health Agency and other government healthcare systems. The company's consistent competitive success across multiple therapeutic domains demonstrates its capability to fulfill federal medical supply requirements efficiently and reliably.
Quick answers
Who was awarded contract SPE2DR26F9LX7?
SPE2DR26F9LX7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LX7 worth?
The government has obligated $26,345 on SPE2DR26F9LX7.
Is contract SPE2DR26F9LX7 an order under another contract?
Yes. SPE2DR26F9LX7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LX7 competed?
The extent of competition for SPE2DR26F9LX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award